Global Attention Deficit Hyperactivity Disorder (ADHD) Supply, Demand and Key Producers, 2024-2030

Page: 127

Published Date: 27 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Attention Deficit Hyperactivity Disorder (ADHD) market size is expected to reach $ 19460 million by 2030, rising at a market growth of 6.4% CAGR during the forecast period (2024-2030).

There are two main types of drugs used to treat ADHD: stimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.

ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.

Effective treatment of ADHD.  ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

This report studies the global Attention Deficit Hyperactivity Disorder (ADHD) demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Attention Deficit Hyperactivity Disorder (ADHD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Attention Deficit Hyperactivity Disorder (ADHD) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Attention Deficit Hyperactivity Disorder (ADHD) total market, 2019-2030, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Attention Deficit Hyperactivity Disorder (ADHD) total market, key domestic companies and share, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) revenue by player and market share 2019-2024, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by Type, CAGR, 2019-2030, (USD Million)
Global Attention Deficit Hyperactivity Disorder (ADHD) total market by Distribution Channel, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Attention Deficit Hyperactivity Disorder (ADHD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and Noven Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Attention Deficit Hyperactivity Disorder (ADHD) market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Distribution Channel. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Attention Deficit Hyperactivity Disorder (ADHD) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Attention Deficit Hyperactivity Disorder (ADHD) Market, Segmentation by Type
    Stimulant
    Non-stimulant

Global Attention Deficit Hyperactivity Disorder (ADHD) Market, Segmentation by Distribution Channel
    Hospital Pharmacy
    Retail Pharmacy

Companies Profiled:
    Takeda
    Johnson & Johnson
    Novartis
    Eli Lilly
    Tris Pharma
    Neos Therapeutics
    Mallinckrodt
    Amneal Pharmaceuticals
    Noven Pharmaceuticals
    Purdue Parma
    CTFH

Key Questions Answered
1. How big is the global Attention Deficit Hyperactivity Disorder (ADHD) market?
2. What is the demand of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
3. What is the year over year growth of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
4. What is the total value of the global Attention Deficit Hyperactivity Disorder (ADHD) market?
5. Who are the major players in the global Attention Deficit Hyperactivity Disorder (ADHD) market?

Table of Contents

1 Supply Summary
    1.1 Attention Deficit Hyperactivity Disorder (ADHD) Introduction
    1.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Attention Deficit Hyperactivity Disorder (ADHD) Total Market by Region (by Headquarter Location)
        1.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.5 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.6 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.7 ASEAN Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
        1.3.8 India Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Attention Deficit Hyperactivity Disorder (ADHD) Major Market Trends

2 Demand Summary
    2.1 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.2 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region
        2.2.1 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024)
        2.2.2 World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Region (2025-2030)
    2.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.4 China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.5 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.6 Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.7 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.8 ASEAN Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)
    2.9 India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030)

3 World Attention Deficit Hyperactivity Disorder (ADHD) Companies Competitive Analysis
    3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Attention Deficit Hyperactivity Disorder (ADHD) in 2023
        3.2.3 Global Concentration Ratios (CR8) for Attention Deficit Hyperactivity Disorder (ADHD) in 2023
    3.3 Attention Deficit Hyperactivity Disorder (ADHD) Company Evaluation Quadrant
    3.4 Attention Deficit Hyperactivity Disorder (ADHD) Market: Overall Company Footprint Analysis
        3.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market: Region Footprint
        3.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
        3.4.3 Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Comparison
        4.2.1 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Attention Deficit Hyperactivity Disorder (ADHD) Companies and Market Share, 2019-2024
        4.3.1 United States Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024)
    4.4 China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share, 2019-2024
        4.4.1 China Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024)
    4.5 Rest of World Based Attention Deficit Hyperactivity Disorder (ADHD) Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Stimulant
        5.2.2 Non-stimulant
    5.3 Market Segment by Type
        5.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024)
        5.3.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030)
        5.3.3 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2019-2030)

6 Market Analysis by Distribution Channel
    6.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Overview by Distribution Channel: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Distribution Channel
        6.2.1 Hospital Pharmacy
        6.2.2 Retail Pharmacy
    6.3 Market Segment by Distribution Channel
        6.3.1 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024)
        6.3.2 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030)
        6.3.3 World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2030)

7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Details
        7.1.2 Takeda Major Business
        7.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Takeda Recent Developments/Updates
        7.1.6 Takeda Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Eli Lilly
        7.4.1 Eli Lilly Details
        7.4.2 Eli Lilly Major Business
        7.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Eli Lilly Recent Developments/Updates
        7.4.6 Eli Lilly Competitive Strengths & Weaknesses
    7.5 Tris Pharma
        7.5.1 Tris Pharma Details
        7.5.2 Tris Pharma Major Business
        7.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Tris Pharma Recent Developments/Updates
        7.5.6 Tris Pharma Competitive Strengths & Weaknesses
    7.6 Neos Therapeutics
        7.6.1 Neos Therapeutics Details
        7.6.2 Neos Therapeutics Major Business
        7.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Neos Therapeutics Recent Developments/Updates
        7.6.6 Neos Therapeutics Competitive Strengths & Weaknesses
    7.7 Mallinckrodt
        7.7.1 Mallinckrodt Details
        7.7.2 Mallinckrodt Major Business
        7.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Mallinckrodt Recent Developments/Updates
        7.7.6 Mallinckrodt Competitive Strengths & Weaknesses
    7.8 Amneal Pharmaceuticals
        7.8.1 Amneal Pharmaceuticals Details
        7.8.2 Amneal Pharmaceuticals Major Business
        7.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Amneal Pharmaceuticals Recent Developments/Updates
        7.8.6 Amneal Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Noven Pharmaceuticals
        7.9.1 Noven Pharmaceuticals Details
        7.9.2 Noven Pharmaceuticals Major Business
        7.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Noven Pharmaceuticals Recent Developments/Updates
        7.9.6 Noven Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Purdue Parma
        7.10.1 Purdue Parma Details
        7.10.2 Purdue Parma Major Business
        7.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Purdue Parma Recent Developments/Updates
        7.10.6 Purdue Parma Competitive Strengths & Weaknesses
    7.11 CTFH
        7.11.1 CTFH Details
        7.11.2 CTFH Major Business
        7.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
        7.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 CTFH Recent Developments/Updates
        7.11.6 CTFH Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Attention Deficit Hyperactivity Disorder (ADHD) Industry Chain
    8.2 Attention Deficit Hyperactivity Disorder (ADHD) Upstream Analysis
    8.3 Attention Deficit Hyperactivity Disorder (ADHD) Midstream Analysis
    8.4 Attention Deficit Hyperactivity Disorder (ADHD) Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Attention Deficit Hyperactivity Disorder (ADHD) Players in 2023
    Table 12. World Attention Deficit Hyperactivity Disorder (ADHD) Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Attention Deficit Hyperactivity Disorder (ADHD) Company Evaluation Quadrant
    Table 14. Head Office of Key Attention Deficit Hyperactivity Disorder (ADHD) Player
    Table 15. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Type Footprint
    Table 16. Attention Deficit Hyperactivity Disorder (ADHD) Market: Company Product Application Footprint
    Table 17. Attention Deficit Hyperactivity Disorder (ADHD) Mergers & Acquisitions Activity
    Table 18. United States VS China Attention Deficit Hyperactivity Disorder (ADHD) Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share (2019-2024)
    Table 23. China Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Attention Deficit Hyperactivity Disorder (ADHD) Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share (2019-2024)
    Table 29. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel, (USD Million), 2019 & 2023 & 2030
    Table 33. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2019-2024) & (USD Million)
    Table 34. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2025-2030) & (USD Million)
    Table 35. Takeda Basic Information, Area Served and Competitors
    Table 36. Takeda Major Business
    Table 37. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 38. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Takeda Recent Developments/Updates
    Table 40. Takeda Competitive Strengths & Weaknesses
    Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 42. Johnson & Johnson Major Business
    Table 43. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 44. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Johnson & Johnson Recent Developments/Updates
    Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 50. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Novartis Competitive Strengths & Weaknesses
    Table 53. Eli Lilly Basic Information, Area Served and Competitors
    Table 54. Eli Lilly Major Business
    Table 55. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 56. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Eli Lilly Recent Developments/Updates
    Table 58. Eli Lilly Competitive Strengths & Weaknesses
    Table 59. Tris Pharma Basic Information, Area Served and Competitors
    Table 60. Tris Pharma Major Business
    Table 61. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 62. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Tris Pharma Recent Developments/Updates
    Table 64. Tris Pharma Competitive Strengths & Weaknesses
    Table 65. Neos Therapeutics Basic Information, Area Served and Competitors
    Table 66. Neos Therapeutics Major Business
    Table 67. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 68. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Neos Therapeutics Recent Developments/Updates
    Table 70. Neos Therapeutics Competitive Strengths & Weaknesses
    Table 71. Mallinckrodt Basic Information, Area Served and Competitors
    Table 72. Mallinckrodt Major Business
    Table 73. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 74. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Mallinckrodt Recent Developments/Updates
    Table 76. Mallinckrodt Competitive Strengths & Weaknesses
    Table 77. Amneal Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Amneal Pharmaceuticals Major Business
    Table 79. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 80. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Amneal Pharmaceuticals Recent Developments/Updates
    Table 82. Amneal Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Noven Pharmaceuticals Basic Information, Area Served and Competitors
    Table 84. Noven Pharmaceuticals Major Business
    Table 85. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 86. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Noven Pharmaceuticals Recent Developments/Updates
    Table 88. Noven Pharmaceuticals Competitive Strengths & Weaknesses
    Table 89. Purdue Parma Basic Information, Area Served and Competitors
    Table 90. Purdue Parma Major Business
    Table 91. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 92. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Purdue Parma Recent Developments/Updates
    Table 94. CTFH Basic Information, Area Served and Competitors
    Table 95. CTFH Major Business
    Table 96. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product and Services
    Table 97. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 98. Global Key Players of Attention Deficit Hyperactivity Disorder (ADHD) Upstream (Raw Materials)
    Table 99. Attention Deficit Hyperactivity Disorder (ADHD) Typical Customers
List of Figure
    Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Picture
    Figure 2. World Attention Deficit Hyperactivity Disorder (ADHD) Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Attention Deficit Hyperactivity Disorder (ADHD) Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Attention Deficit Hyperactivity Disorder (ADHD) Revenue (2019-2030) & (USD Million)
    Figure 13. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Attention Deficit Hyperactivity Disorder (ADHD) by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Attention Deficit Hyperactivity Disorder (ADHD) Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Attention Deficit Hyperactivity Disorder (ADHD) Markets in 2023
    Figure 27. United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Attention Deficit Hyperactivity Disorder (ADHD) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type in 2023
    Figure 31. Stimulant
    Figure 32. Non-stimulant
    Figure 33. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2019-2030)
    Figure 34. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel in 2023
    Figure 36. Hospital Pharmacy
    Figure 37. Retail Pharmacy
    Figure 38. Attention Deficit Hyperactivity Disorder (ADHD) Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH

Related Reports

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Attention Deficit Hyperactivity Disorder (ADHD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Attention Deficit Hyperactivity Disorder (ADHD) market size was valued at USD 12590 million in 2023 and is forecast to a readjusted size of USD 19460 million by 2030 with a CAGR of 6.4% during review period.

Product Tags

attention deficit hyperactivity disorder adhd

attention deficit hyperactivity disorder adhd therapeutics

attention deficit hyperactivity disorder adhd drugs

Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD) Drugs

Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics

Attention Deficit Hyperactivity Disorder (ADHD) Treatment

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>